Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05669222 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The FAVOR V AMI Trial

StatusRecruiting
PhaseNot applicable
Started2023-01-17
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 36 months later Jun 2025 → Jun 30, 2028
See other at-risk trials from China National Center for Cardiovascular Diseases

Amendment history

2026-09-25
Recruitment opened
Primary completion pushed: 2025-06 → 2028-06-30
Completion pushed: 2028-06 → 2033-06-30
2023-09-10
Study Status v2
Start date2023-01-20→2023-09-30
2023-01-01
Study Status v1
Start date2022-12→2023-01-20
2022-12-27
Original filing
The FAVOR V AMI study is a prospective, multicenter, blinded, randomized, sham-controlled trial comparing the long-term clinical outcomes of the "Functional and Angiography-derived Strain inTegration (FAST)" technique (next-generation quantitative flow ratio \[μQFR\] and radial wall strain \[RWS\]) guided percutaneous coronary intervention (PCI) strategy, with standard treatment strategy, in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary disease (MVD).
Trial Details
NCT Number NCT05669222
Lead Sponsor China National Center for Cardiovascular Diseases
Conditions ST-Segment Elevation Myocardial Infarction, Multivessel Coronary Artery Disease, Percutaneous Coronary Intervention
Enrollment 5,000 participants
Start Date 2023-01-17
Primary Completion 2028-06-30 (estimated)
Study Completion 2033-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-24